Hypothermia: Pathophysiology, Clinical Recognition, and Evidence-Based Management for Cold-Exposure Emergencies

Hypothermia is a potentially life-threatening decline in core body temperature due to impaired heat production or excessive heat loss. Clinically, it is commonly defined as a core temperature below 35°C (95°F). Cold exposure may occur in outdoors settings, during prolonged inactivity, or in cases of inadequate clothing, immersion, or environmental wind and wetness. Regardless of context, the underlying physiology centers on heat balance, cardiovascular stability, and the body’s ability to regulate temperature through thermoregulatory reflexes.

Thermoregulation normally involves hypothalamic integration of afferent temperature signals from peripheral receptors and skin, coordinated with autonomic responses and behavioral drive. When environmental conditions overwhelm these mechanisms, vasoconstriction initially limits heat loss by reducing cutaneous blood flow. Shivering increases metabolic heat production through involuntary skeletal muscle activity. With progressive cooling, the body exhausts these compensatory pathways. Peripheral vasoconstriction becomes less effective, shivering may cease, and metabolic demand may paradoxically decrease due to systemic dysfunction.

As core temperature falls, cellular and organ systems experience enzyme dysfunction, membrane instability, and impaired mitochondrial energy production. The cardiovascular system becomes particularly vulnerable: myocardial contractility declines, conduction slows, and arrhythmia risk rises. Hypothermia is associated with bradycardia and prolonged PR/QRS intervals; severe cases can develop ventricular fibrillation or asystole. Respiratory drive and protective airway reflexes also deteriorate, increasing aspiration and hypoventilation risk. Coagulation pathways are altered, producing a complex “hypothermia-associated coagulopathy,” which can worsen bleeding and complicate trauma care.

Clinically, symptom severity correlates with temperature but varies by age, comorbidities, and exposure duration. Mild hypothermia often presents with cold extremities, shivering, tachypnea or mild tachycardia early, altered dexterity, and impaired judgment. Moderate hypothermia may show persistent shivering followed by reduced responsiveness, slurred speech, poor coordination, and worsening mental status. In severe hypothermia, shivering typically stops, consciousness may be absent, pupils may be fixed or dilated, vital signs become markedly abnormal, and patients can appear “dead” yet still have reversible physiology if rewarming is prompt.

Diagnosis relies on accurate core temperature measurement. Reliance on axillary or skin readings can underestimate severity. Preferred methods include esophageal, bladder, or tympanic measurements in appropriate settings, or rectal probes when clinically indicated. The evaluation should also consider precipitating factors such as intoxication, hypoglycemia, sepsis, endocrine disorders (e.g., hypothyroidism), and environmental exposure. Basic laboratory assessment—glucose, electrolytes, arterial blood gas when feasible, and coagulation studies—helps identify reversible contributors.

Management prioritizes careful rewarming, hemodynamic stabilization, and prevention of further heat loss. Immediate actions include removing wet clothing, insulating the patient, protecting from wind, and using warmed blankets or reflective materials. In mild hypothermia with preserved perfusion, external rewarming is often sufficient: forced-air warming, radiant heat, and warmed humidified oxygen support. For moderate to severe hypothermia, active internal rewarming is recommended. Options may include warmed intravenous fluids, warmed inhaled gases, bladder or gastric lavage with warmed solutions, and in refractory cases, extracorporeal rewarming (e.g., cardiopulmonary bypass or ECMO) at specialized centers.

Airway and breathing require vigilance. Hypothermic patients have diminished ventilatory drive and may have depressed mental status. Provide supplemental oxygen and consider airway protection if the patient cannot maintain airway reflexes. Circulation management focuses on treating bradyarrhythmias and supporting perfusion; however, the use of ACLS medications and defibrillation should be individualized because hypothermia alters drug kinetics and the effectiveness of electrical therapy. Many protocols emphasize withholding definitive rhythm interventions until core temperature rises above thresholds where pharmacology and defibrillation become more reliable, while still addressing reversible causes.

Prognosis depends on lowest core temperature, duration of exposure, underlying comorbidities, and the timeliness and effectiveness of rewarming. Neurologic outcomes can be affected by prolonged hypoxia, hypotension, and coagulopathy. Even in severe presentations, hypothermia is sometimes uniquely reversible compared with normothermic cardiac arrest, supporting aggressive rewarming and careful resuscitation when appropriate.

Prevention is clinically important: layered clothing, waterproof outerwear, shelter from wind, attention to hydration and caloric intake, and prompt treatment of alcohol intoxication and hypoglycemia. High-risk groups include older adults, infants, people with psychiatric illness who may become immobilized, individuals with impaired thermoregulation, and those taking sedatives or antipsychotics.

In summary, hypothermia is a systemic failure of heat balance with cascading cardiovascular, respiratory, coagulation, and neurologic dysfunction. Effective care requires precise core temperature measurement, rapid assessment for underlying causes, and staged rewarming—external for mild cases and internal or extracorporeal strategies for moderate to severe illness—along with careful airway, breathing, and circulation support. Source: @Ken_City_